These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14167103)

  • 1. [ON THE BEHAVIOR OF THE COAGULATIONS FACTORS PROTHROMBIN, FACTOR V AND FACTOR VII IN RATS FOLLOWING TOTAL-BODY IRRADIATION; DEPENDENCE ON DOSE AND THE EFFECT OF SPLEEN EXCISION].
    KLESPER R; KESSLER FJ; FELDERHOFF B; PARCHWITZ HK; WITTEKIND E
    Thromb Diath Haemorrh; 1964 Apr; 11():204-9. PubMed ID: 14167103
    [No Abstract]   [Full Text] [Related]  

  • 2. [BLOOD CLOTTING FACTORS IN RENAL DISEASES].
    SATAKE K
    Nihon Ketsueki Gakkai Zasshi; 1963 Dec; 26():767-78. PubMed ID: 14154694
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of phenylindanedione on the coagulation factors prothrombin, factor V and factor VII and the question of vitamin K resistance].
    PERLICK E
    Klin Wochenschr; 1953 Mar; 31(11-12):261-3. PubMed ID: 13070456
    [No Abstract]   [Full Text] [Related]  

  • 4. OBSERVATIONS ON THE INTERACTION OF PHOSPHOLIPIDS AND CERTAIN CLOTTING FACTORS IN PROTHROMBIN ACTIVATOR FORMATION.
    PAPAHADJOPOULOS D; HANAHAN DJ
    Biochim Biophys Acta; 1964 Aug; 90():436-9. PubMed ID: 14220741
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on the prothrombin complex in mature and and premature infants. I. On prothrombin, factor V and factor VII-complex in mature and premature infants].
    MORII N
    Paediatr Jpn; 1961; 65():260-7. PubMed ID: 13772659
    [No Abstract]   [Full Text] [Related]  

  • 6. [CHANGES IN THE ACTIVITY OF INDIVIDUAL FACTORS OF THE PROTHROMBIN COMPLEX IN AGING OF THE PLASMA].
    MARES J; PODLIPNY J
    Z Arztl Fortbild (Jena); 1964 Jun; 58():655-8. PubMed ID: 14241491
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical studies on blood coagulation factors, prothrombin, factor V and factor VII liver diseases and their response to vitamin K1 and synka-vit].
    WITTE S; DIRNBERGER P
    Klin Wochenschr; 1953 Sep; 31(33-34):781-7. PubMed ID: 13097910
    [No Abstract]   [Full Text] [Related]  

  • 8. [THE BEHAVIOR OF DIFFERENT BLOOD COAGULATION FACTORS IN IRRADIATION OF GYNECOLOGICAL CARCINOMA WITH COBALT 60].
    GRAEBER W
    Strahlentherapie; 1964 May; 124():60-8. PubMed ID: 14216959
    [No Abstract]   [Full Text] [Related]  

  • 9. [STUDIES ON THE RELATIONS BETWEEN VASCULAR AND BLOOD COAGULATION FACTORS IN THE SANARELLI-SHWARTZMAN PHENOMENON].
    MUELLER-BERGHAUS G; LASCH HG
    Thromb Diath Haemorrh; 1963 Jul; 143():335-45. PubMed ID: 14081257
    [No Abstract]   [Full Text] [Related]  

  • 10. [QUANTITATIVE BLOOD COAGULATION TESTS].
    HEMKER HC
    Maandschr Kindergeneeskd; 1964 Aug; 32():503-11. PubMed ID: 14209521
    [No Abstract]   [Full Text] [Related]  

  • 11. COAGULATION STUDIES WITH FETAL BLOOD.
    HEIKINHEIMO R
    Biol Neonat; 1964; 7():319-27. PubMed ID: 14319194
    [No Abstract]   [Full Text] [Related]  

  • 12. OMEPHINE, A NEW ANTICOAGULANT.
    KOPTELOVA MN
    Fed Proc Transl Suppl; 1963; 22():1256-8. PubMed ID: 14079350
    [No Abstract]   [Full Text] [Related]  

  • 13. [FUNCTIONAL RELATION BETWEEN ERYTHROPLASTIN (ERYTHROCYTE COAGULANT FACTOR) AND PLASMA FACTORS: PROACCELERIN (V), PROCONVERTIN (VII) AND STUART FACTOR(X)].
    GAERTNER H; CAEN J
    Acta Physiol Pol; 1964; 15():237-43. PubMed ID: 14227143
    [No Abstract]   [Full Text] [Related]  

  • 14. [The behavior of prothrombin, of factor V and of factor VII before and after exchange transfusion].
    FELICI W
    Minerva Pediatr; 1959 Jul; 11():756-61. PubMed ID: 13822081
    [No Abstract]   [Full Text] [Related]  

  • 15. DETERMINANTS OF THE CLOTTING FACTOR RESPONSE TO WARFARIN IN THE RAT.
    PYOERAELAE K
    Ann Med Exp Biol Fenn; 1965; 43():SUPPL 3:1-99. PubMed ID: 14342207
    [No Abstract]   [Full Text] [Related]  

  • 16. [Influence of massive doses if vitamin K1 on the coagulation factors prothrombin, factor V and factor VII in liver diseases].
    GUNTHER PG; KIEFER E
    Med Klin; 1955 Nov; 50(46):1944-8. PubMed ID: 13287765
    [No Abstract]   [Full Text] [Related]  

  • 17. [BLOOD CLOTTING FACTOR IN HEMOLYSATES].
    OGIWARA Y
    Nihon Ketsueki Gakkai Zasshi; 1963 Dec; 26():779-87. PubMed ID: 14154695
    [No Abstract]   [Full Text] [Related]  

  • 18. [EFFECTS OF CHLORTETRACYCLINE ON THE BLOOD COAGULATION PROCESSES].
    ONDRACEK Z; MLEJNKOVA M; SVEHLA C; SP'ANKOVA H
    Cas Lek Cesk; 1963 May; 102():532-3. PubMed ID: 14073557
    [No Abstract]   [Full Text] [Related]  

  • 19. HEPARIN AND SOME COAGULATION FACTORS IN EXPERIMENTAL BURN INJURIES.
    JOHANSSON SA
    Acta Chir Scand; 1964 Oct; 128():346-9. PubMed ID: 14211289
    [No Abstract]   [Full Text] [Related]  

  • 20. [STUDIES ON THE EFFECTS OF MITOMYCIN C AGAINST PATIENTS WITH MALIGNANT TUMORS, PARTICULARLY ON THE CHANGES OF COAGULATING FACTORS].
    YAMADA K
    Naika Hokan; 1964 May; 11():207-16. PubMed ID: 14180228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.